IL17A and chronic obstructive pulmonary disease: Moreover, this cytokine is identified in the pulmonary biopsies of patients with COPD and in the sputum of patients during exacerbations of the disease [55], suggesting that although our model is a short exposure, the increase in IL-17 levels induced by conventional and e-cig may increase the risk of EC might elevate the risk of COPD development.